BioMS Will Give $10m to MS Drug Testing

A clinical study for secondary progressive multiple scleroses will be being conducted by BioMS Medical Corp will receive $10 million from Eli Lilly and Co. BioMS Medical Corp is a leader in developing treatments for MS, and Eli Lilly will contribute their money towards the licensing and collaboration agreements. They signed on to the study after an independent drug safety company gave the treatment an OK. This was reported by FDA News.